Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Titel:
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Auteur:
Hanna, Michael G Badrising, Umesh A Benveniste, Olivier Lloyd, Thomas E Needham, Merrilee Chinoy, Hector Aoki, Masashi Machado, Pedro M Liang, Christina Reardon, Katrina A de Visser, Marianne Ascherman, Dana P Barohn, Richard J Dimachkie, Mazen M Miller, James A L Kissel, John T Oskarsson, Björn Joyce, Nanette C Van den Bergh, Peter Baets, Jonathan De Bleecker, Jan L Karam, Chafic David, William S Mirabella, Massimiliano Nations, Sharon P Jung, Hans H Pegoraro, Elena Maggi, Lorenzo Rodolico, Carmelo Filosto, Massimiliano Shaibani, Aziz I Sivakumar, Kumaraswamy Goyal, Namita A Mori-Yoshimura, Madoka Yamashita, Satoshi Suzuki, Naoki Katsuno, Masahisa Murata, Kenya Nodera, Hiroyuki Nishino, Ichizo Romano, Carla D Williams, Valerie S L Vissing, John Auberson, Lixin Zhang Wu, Min de Vera, Ana Papanicolaou, Dimitris A Amato, Anthony A